Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 556 citations
https://doi.org/10.1016/s0140-6736(21)00149-5
A
Ashley Baldwin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
3.5K
Citations
13
h-index
13
i10-index
Ashley Baldwin is an academic researcher from University of Liverpool. The author has contributed to research in topics: Dementia and Cognitive Impairment Research & COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 13, co-authored 31 publications.
ORCID: 0000-0003-0344-6086Papers by this author
worksConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · The Lancet · 516 citations
https://doi.org/10.1016/s0140-6736(21)00897-7
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · The Lancet · 320 citations
https://doi.org/10.1016/s0140-6736(22)01109-6
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 289 citations
https://doi.org/10.1016/s0140-6736(21)01825-0
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses
2015 · The Lancet Neurology · 160 citations
https://doi.org/10.1016/s1474-4422(15)00258-6
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease – a multicentre RCT
2009 · Trials · 54 citations
https://doi.org/10.1186/1745-6215-10-57
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat